AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34049908 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyurethane-covered implants
Number of subjects: 321
Study 34049908 — intervention group
Group type: COMPARATOR
Intervention: Textured implants
Number of subjects: 321
Study 32578404 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Psychology Intervention (PPI) over 42 days
Number of subjects: 86
Study 32578404 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 86
Study 34786651 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone 10 or 20 mg once daily, titrated based on serum potassium and estimated glomerular filtration rate.
Number of subjects: 5734
Study 34786651 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone (10 to 20 mg)
Number of subjects: 5734
Study 34786651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5734
Study 33239108 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 μg/kg/min landiolol infusion
Number of subjects: 16
Study 33239108 — intervention group
Group type: EXPERIMENTAL
Intervention: Termination of landiolol infusion
Number of subjects: 16
Study 33239108 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacokinetics of landiolol
Number of subjects: 16
Study 34333211 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led eHealth cardiac rehabilitation (NeCR)
Number of subjects: 146
Study 34333211 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 146
Study 32703038 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg policosanol (group A)
Number of subjects: 294
Study 32703038 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg policosanol (group B)
Number of subjects: 294
Study 32703038 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg atorvastatin (group C)
Number of subjects: 294
Study 32703038 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg policosanol + 20 mg atorvastatin (group D)
Number of subjects: 294
Study 32703038 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 294
Study 35658002 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab plus Pembrolizumab (RP)
Number of subjects: 136
Study 35658002 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 136
Study 34533542 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% povidone-iodine applied to the external auditory canal for 10 minutes
Number of subjects: 0
Study 34533542 — intervention group
Group type: COMPARATOR
Intervention: Control group with povidone-iodine not allowed to enter the external auditory canal
Number of subjects: 0
Study 32749605 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual inspection
Number of subjects: 114
Study 32749605 — intervention group
Group type: COMPARATOR
Intervention: Computed tomography (CT) imaging
Number of subjects: 114
Study 32749605 — intervention group
Group type: COMPARATOR
Intervention: Clinical examination
Number of subjects: 114
Study 34995796 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP and GLP-2 co-administration
Number of subjects: 10
Study 34995796 — intervention group
Group type: COMPARATOR
Intervention: GIP alone
Number of subjects: 10
Study 34995796 — intervention group
Group type: COMPARATOR
Intervention: GLP-2 alone
Number of subjects: 10
Study 32504207 — intervention group
Group type: EXPERIMENTAL
Intervention: Small stitches technique using Monomax® 2‐0
Number of subjects: 100
Study 32504207 — intervention group
Group type: COMPARATOR
Intervention: Large stitches technique using PDS II® 1 loop
Number of subjects: 100
Study 35643280 — intervention group
Group type: EXPERIMENTAL
Intervention: OIT with antihistamines
Number of subjects: 43
Study 35643280 — intervention group
Group type: EXPERIMENTAL
Intervention: OIT with placebo antihistamines
Number of subjects: 43
Study 35643280 — intervention group
Group type: EXPERIMENTAL
Intervention: OIT
Number of subjects: 43
Study 35643280 — intervention group
Group type: EXPERIMENTAL
Intervention: OIT without antihistamines
Number of subjects: 43
Study 33883635 — intervention group
Group type: EXPERIMENTAL
Intervention: HIFT
Number of subjects: 35
Study 33883635 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 35
Study 33883635 — intervention group
Group type: EXPERIMENTAL
Intervention: HIPT
Number of subjects: 35
Study 33883635 — intervention group
Group type: EXPERIMENTAL
Intervention: HIET
Number of subjects: 35
Study 33883635 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 35
Study 32128716 — intervention group
Group type: EXPERIMENTAL
Intervention: Active play (3 hours)
Number of subjects: 32
Study 32128716 — intervention group
Group type: COMPARATOR
Intervention: Sedentary screen time (3 hours)
Number of subjects: 32
Study 32128716 — intervention group
Group type: COMPARATOR
Intervention: Sedentary screen time
Number of subjects: 32
Study 32128716 — intervention group
Group type: EXPERIMENTAL
Intervention: High-calorie food pictures
Number of subjects: 32
Study 32128716 — intervention group
Group type: EXPERIMENTAL
Intervention: Hunger measurement
Number of subjects: 32
Study 35950949 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-monthly viral load testing and sequential point-of-care drug exposure testing and DBS-based drug resistance testing in case of rebound above 1000 copies/ml
Number of subjects: 501
Study 35950949 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care monitoring according to WHO guidelines
Number of subjects: 501
Study 35950949 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-monthly viral load testing
Number of subjects: 501
Study 35950949 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care annual viral load testing
Number of subjects: 501
Study 34473405 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST)
Number of subjects: 110
Study 34473405 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pre-exposure prophylaxis (PrEP)
Number of subjects: 110
Study 34473405 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) and Oral pre-exposure prophylaxis (PrEP)
Number of subjects: 110
Study 35329390 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy program to train strength and coordination of the masticatory muscles, details on dosage and duration not available.
Number of subjects: 0
Study 35329390 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel methodology for recruitment process for people with dementia, details not available.
Number of subjects: 0
Study 34406856 — intervention group
Group type: EXPERIMENTAL
Intervention: mPalliative Care Link (mPCL)
Number of subjects: 98
Study 34406856 — intervention group
Group type: COMPARATOR
Intervention: Phone-contact POS collection
Number of subjects: 98
Study 36119062 — intervention group
Group type: EXPERIMENTAL
Intervention: BK-SE36 (intramuscular route)
Number of subjects: 108
Study 36119062 — intervention group
Group type: EXPERIMENTAL
Intervention: BK-SE36 (subcutaneous route)
Number of subjects: 108
Study 36119062 — intervention group
Group type: COMPARATOR
Intervention: Control vaccine (Synflorix® via IM route)
Number of subjects: 108
Study 36119062 — intervention group
Group type: EXPERIMENTAL
Intervention: BK-SE36 (both routes)
Number of subjects: 108
Study 34719267 — intervention group
Group type: EXPERIMENTAL
Intervention: Good cartilage status (ICRS grade I or II; n = 70)
Number of subjects: 155
Study 34719267 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor cartilage status (ICRS grade III or IV; n = 85)
Number of subjects: 155
Study 32633993 — intervention group
Group type: EXPERIMENTAL
Intervention: pCS20 quantitative polymerase chain reaction (qPCR) assay
Number of subjects: 3792
Study 32633993 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequencing of positive samples
Number of subjects: 3792
Study 32633993 — intervention group
Group type: EXPERIMENTAL
Intervention: Phylogenetic analysis
Number of subjects: 3792
Study 32633993 — intervention group
Group type: EXPERIMENTAL
Intervention: Propagation in cell cultures
Number of subjects: 3792
Study 35434945 — intervention group
Group type: EXPERIMENTAL
Intervention: Okra whole fruit capsules (1,000 mg) taken orally every 6 hours for 8 weeks
Number of subjects: 120
Study 35434945 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule taken orally every 6 hours for 8 weeks
Number of subjects: 120
Study 33764191 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians' expressed beliefs to patients about poor prognoses
Number of subjects: 398
Study 33764191 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians' expressed beliefs to patients about prognoses
Number of subjects: 398
Study 33764191 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for differences in beliefs
Number of subjects: 398
Study 32252101 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg BM)
Number of subjects: 8
Study 32252101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 34580053 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening with prostate-specific antigen (PSA) followed by magnetic resonance imaging (MRI)
Number of subjects: 61201
Study 33298001 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based training along with text messaging
Number of subjects: 75
Study 33298001 — intervention group
Group type: EXPERIMENTAL
Intervention: CD-based training
Number of subjects: 75
Study 33298001 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 35337312 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face training for 6 hours with slides, lectures, and practical work on intubation, LMA, CPR, and AED.
Number of subjects: 87
Study 35337312 — intervention group
Group type: COMPARATOR
Intervention: Virtual training using a training video on CD with full explanation of project objectives.
Number of subjects: 87
Study 34365019 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Frequency Left (HFL)
Number of subjects: 414
Study 34365019 — intervention group
Group type: EXPERIMENTAL
Intervention: intermittent theta burst stimulation (iTBS)
Number of subjects: 414
Study 32362221 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified quadruple therapy (rabeprazole 20 mg bid, amoxicillin 1 g bid, metronidazole 500 mg tid, bismuth subcitrate 300 mg qid)
Number of subjects: 233
Study 32362221 — intervention group
Group type: COMPARATOR
Intervention: Bismuth-containing quadruple therapy (rabeprazole 20 mg bid, bismuth subcitrate 300 mg qid, metronidazole 500 mg tid, tetracycline 500 mg qid)
Number of subjects: 233
Study 32362221 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 233
Study 34882603 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical refractions
Number of subjects: 30
Study 34882603 — intervention group
Group type: EXPERIMENTAL
Intervention: Pupil fraction tessellated refractions
Number of subjects: 30
Study 34882603 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Strehl ratio refractions
Number of subjects: 30
Study 33235122 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic repair with platelet-rich plasma (PRP)
Number of subjects: 0
Study 33235122 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic repair without platelet-rich plasma (Control)
Number of subjects: 0
Study 36011825 — intervention group
Group type: EXPERIMENTAL
Intervention: Binaural beat audio
Number of subjects: 61
Study 36011825 — intervention group
Group type: COMPARATOR
Intervention: Sham-control (ear phones with no music)
Number of subjects: 61
Study 33250383 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 59
Study 33250383 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 59
Study 36228195 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotadutide
Number of subjects: 0
Study 33347732 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy by passive listening to music for 30 minutes/day, 5 days/week for 4 weeks, along with DASH eating plan
Number of subjects: 30
Study 33347732 — intervention group
Group type: COMPARATOR
Intervention: DASH eating plan and sodium restriction
Number of subjects: 30
Study 32433709 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood cadmium quartile 2 (0.54-0.92 μg/L)
Number of subjects: 1008
Study 32433709 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood cadmium quartile 3 (0.93-1.62 μg/L)
Number of subjects: 1008
Study 32433709 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood cadmium quartile 4 (1.63-57.81 μg/L)
Number of subjects: 1008
Study 32433709 — intervention group
Group type: COMPARATOR
Intervention: Lowest blood cadmium quartile (0.00-0.53 μg/L)
Number of subjects: 1008
Study 35443242 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncorrection (N)
Number of subjects: 66
Study 35443242 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold difference (A1)
Number of subjects: 66
Study 35443242 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression equation (A2)
Number of subjects: 66
Study 32019509 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (GCBT) plus treatment as usual (TAU)
Number of subjects: 112
Study 32019509 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (WL) plus treatment as usual (TAU)
Number of subjects: 112
Study 35505452 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia pretreatment with lidocaine‐prilocaine cream (EMLA)
Number of subjects: 62
Study 35505452 — intervention group
Group type: COMPARATOR
Intervention: Water‐based cream (placebo)
Number of subjects: 62
Study 33433024 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone application (app) for central venous catheter care (n = 39)
Number of subjects: 90
Study 33433024 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n = 40)
Number of subjects: 90
Study 33278747 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg t.i.d. plus standard therapy
Number of subjects: 38
Study 33278747 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 38
Study 32564236 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation (13–17-week telephone-guided graduated walking programme)
Number of subjects: 44
Study 32564236 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 44
Study 32564236 — intervention group
Group type: COMPARATOR
Intervention: Prehabilitation vs Control
Number of subjects: 44
Study 34647992 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgotinib 200 mg once daily for 12 weeks
Number of subjects: 116
Study 34647992 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 33927155 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine buffered with sodium bicarbonate
Number of subjects: 199
Study 33927155 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine alone
Number of subjects: 199
Study 33927155 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 199
Study 32377822 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin treatment for non-infectious uveitis
Number of subjects: 50
Study 36387983 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized pharmacotherapy (OPT) with nicotine patch and up to two adaptations to varenicline and bupropion based on smoking status
Number of subjects: 392
Study 36387983 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (UC) with nicotine patch throughout treatment
Number of subjects: 392
Study 32036988 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary 0.06% Cl due to complete substitution of NaCl by Na2SO4
Number of subjects: 360
Study 32036988 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary Cl levels at 0.10% and 0.15%
Number of subjects: 360
Study 32036988 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary 0.10% and 0.15% Cl
Number of subjects: 360
Study 32036988 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary 0.15% Cl
Number of subjects: 360
Study 32036988 — intervention group
Group type: EXPERIMENTAL
Intervention: Na2SO4 partly replacing NaCl in diets
Number of subjects: 360
Study 35620956 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Circuit Training using Body Weight (HICTBW)
Number of subjects: 24
Study 33154431 — intervention group
Group type: EXPERIMENTAL
Intervention: N75P13K25 + microbial consortium
Number of subjects: 0
Study 33154431 — intervention group
Group type: EXPERIMENTAL
Intervention: N150P26K50 + microbial consortium
Number of subjects: 0
Study 33154431 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of 50% NPK with microbial consortium
Number of subjects: 0
Study 33154431 — intervention group
Group type: EXPERIMENTAL
Intervention: N150P26K50 with microbial consortium
Number of subjects: 0
Study 33682454 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission IL-6 levels
Number of subjects: 552
Study 33682454 — intervention group
Group type: COMPARATOR
Intervention: Treatment group
Number of subjects: 552
Study 32998771 — intervention group
Group type: EXPERIMENTAL
Intervention: More than 5 N1 LNs examined
Number of subjects: 2028
Study 32998771 — intervention group
Group type: COMPARATOR
Intervention: 0-5 N1 LNs examined
Number of subjects: 2028
Study 34904800 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5mg/kg)
Number of subjects: 53
Study 34904800 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine (0.25mg/kg)
Number of subjects: 53
Study 33535274 — intervention group
Group type: EXPERIMENTAL
Intervention: Training B (3 directions, 3 minutes duration)
Number of subjects: 48
Study 33535274 — intervention group
Group type: EXPERIMENTAL
Intervention: Everyday training (Training B)
Number of subjects: 48
Study 33535274 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-a-week training (Training B)
Number of subjects: 48
Study 33535274 — intervention group
Group type: EXPERIMENTAL
Intervention: Every-other-day training (Training B)
Number of subjects: 48
Study 33535274 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 48
Study 32999003 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraepithelial CD8+ cell density
Number of subjects: 695
Study 32999003 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-learning, image-based algorithm for quantifying immune cell density
Number of subjects: 695
Study 36331493 — intervention group
Group type: EXPERIMENTAL
Intervention: IUI with ovarian stimulation (IUI-OS)
Number of subjects: 178
Study 36331493 — intervention group
Group type: COMPARATOR
Intervention: Expectant management (EM)
Number of subjects: 178
Study 33341062 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual auscultation teaching strategy (3 sessions, 2 hours each)
Number of subjects: 127
Study 33341062 — intervention group
Group type: COMPARATOR
Intervention: Usual preparation in auscultation learning strategies
Number of subjects: 127
Study 33169787 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromoendoscopy (CE)
Number of subjects: 129
Study 33169787 — intervention group
Group type: COMPARATOR
Intervention: Virtual Chromoendoscopy (VC)
Number of subjects: 129
Study 32171774 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (starting dose of 50 µg daily)
Number of subjects: 185
Study 32171774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 36494824 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-informed intervention including co-designed information videos and posters, in-house staff vaccination clinics, and an incentive scheme.
Number of subjects: 39
Study 36494824 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (control group) with additional monthly data contribution.
Number of subjects: 39
Study 36494824 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-informed intervention
Number of subjects: 39
Study 33721874 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral desaturation defined by <90% baseline for left Scto2
Number of subjects: 175
Study 33721874 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral desaturation defined by <85% baseline for right Scto2
Number of subjects: 175
Study 33721874 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum Scto2
Number of subjects: 175
Study 33721874 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral desaturation defined by other thresholds, cerebral hypersaturation, AUT/AAT, and somatic desaturation and hypersaturation
Number of subjects: 175
Study 32795294 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (6 group education sessions to promote healthy eating)
Number of subjects: 177
Study 32795294 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual nutritional consultation)
Number of subjects: 177
Study 32795294 — intervention group
Group type: COMPARATOR
Intervention: Difference in HOMA‐IR between control and intervention group
Number of subjects: 177
Study 32431191 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tacrolimus 0.1% ointment once a day (QD)
Number of subjects: 40
Study 32431191 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tacrolimus 0.1% ointment once every two days (QOD)
Number of subjects: 40
Study 33987839 — intervention group
Group type: EXPERIMENTAL
Intervention: Disaster preparedness education intervention
Number of subjects: 0
Study 33987839 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35459668 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 80
Study 35459668 — intervention group
Group type: COMPARATOR
Intervention: Sham-HBOT
Number of subjects: 80
Study 33470195 — intervention group
Group type: EXPERIMENTAL
Intervention: Bempedoic acid 180 mg daily
Number of subjects: 14014
Study 33470195 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 14014
Study 33251500 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine plus Azithromycin (HC+AZ)
Number of subjects: 456
Study 33251500 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HC)
Number of subjects: 456
Study 33251500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 456
Study 36111559 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP infusion (6 pmol/kg/min)
Number of subjects: 20
Study 36111559 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study 33352588 — intervention group
Group type: EXPERIMENTAL
Intervention: ENT Learning Program (online learning platform)
Number of subjects: 116
Study 32673226 — intervention group
Group type: EXPERIMENTAL
Intervention: EmotionRegulation
Number of subjects: 214